1 Introduction
Staphylococcus aureus is a common bacterium that often resides quite harmlessly on the skin or in the nose of a healthy person. However, a break in the skin or a weakened immune system can trigger the bacteria to cause minor skin infections or life-threatening diseases such as pneumonia, septicemia, and meningitis. Such infections can be passed on through skin contact or contaminated objects. It is no wonder then that S. aureus is the leading cause of hospital-acquired infections in the United States. Controlling and understanding S. aureus in both hospital and community settings is a significant public health concern that is underscored by the continuous evolution and development of methicillin-resistant S. aureus (MRSA). Recent advances in biotechnology allow molecular epidemiology to play an increasing role in the control of S. aureus [2]. Genotyping these bacteria is critical for the study of strain origin, epidemiology of strain outbreaks, and clonal relatedness and is an invaluable tool for the investigation of hospital outbreaks.